Victor Gabrielian, MD
Nuclear Cardiology · Arcadia, CANPI 1811189822
Payments from drug & device makers
Across 253 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$965
- Novartis$954
- Pfizer$556
- Johnson & Johnson$306
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$218
- Abbott$196
- plus $1K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 67 | $965 |
| Novartis | 62 | $954 |
| Pfizer | 29 | $556 |
| Johnson & Johnson | 17 | $306 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $218 |
| Abbott | 9 | $196 |
| Novo Nordisk | 6 | $135 |
| E.r. Squibb & Sons, L.L.C. | 6 | $111 |
| Sanofi-aventis U.S. LLC | 6 | $101 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $75 |
| Medtronic(2 entities) | 3 | $71 |
| Amarin Pharma, Inc. | 3 | $68 |
| Boston Scientific | 3 | $68 |
| Merck | 3 | $57 |
| Actelion Pharmaceuticals US, Inc. | 3 | $53 |
| Akcea Therapeutics, Inc. | 2 | $49 |
| Impulse Dynamics (USA) Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $39 |
| Lilly USA, LLC | 1 | $35 |
| Heartflow, Inc. | 2 | $33 |
| Lexicon Pharmaceuticals, Inc. | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Bayer | 1 | $25 |
| CMP Pharma, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| Edwards Lifesciences | 1 | $17 |
| Philips North America LLC | 1 | $17 |
| AstraZeneca | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
How this compares
Too few nuclear cardiology providers in Californiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear cardiology in Arcadia
- Ramin EbrahimiLos Angeles$544K
- Teresa DanieleFresno$45K
- Christopher OhSalinas$17K
- Absalom HepnerMission Viejo$9K
- Howard LewinLos Angeles$5K
- Ankit RathodFresno$2K
- Arjun SharmaSacramento$1K
- Kusai AzizVisalia$326
- Thomas WattersSan Mateo$17
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.